ArticleThe oncologist2024

Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma.

Andrew C Johns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.